ARCHIVES

Interview: Burzynski Explains Why He Calls Treatment “Non-Toxic”

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

Tracors’ Prime Contract Includes $1 Million for Additional Tests

May 17, 1974

Triple Combination Chemotherapy Effective For Advanced Colorectal Cancer, Trial Finds

January 27, 2006

European Commission Approves Subcutaneous Rituximab

March 28, 2014

In Brief: HHS Won’t Nominate Fischbach for NIH; Kirschstein in Charge

April 28, 2000

FDA Approves Afinitor For Advanced Kidney Cancer

March 27, 2009

Accrual Picking Up, Still “Nothing To Write Home About;” Unfunded MDs ‘Subsidizing Entire Program”

June 3, 1988